Mamantia, Rejane .
HRN: 23-58-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/09/2023
10/15/2023
IV
25mg
OD
Neonatal Pneuumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes